Which mutual funds hold Procter & Gamble Health Limited?

20 mutual funds hold Procter & Gamble Health Limited as of Oct 2026. The highest weight is 51% held by Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option. Data from official AMFI monthly portfolio disclosures.

What sector is Procter & Gamble Health Limited in?

Procter & Gamble Health Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Procter & Gamble Health Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Procter & Gamble Health Limited is a Small Cap stock ranked #585 with an average market cap of ₹8.92 K Cr.

Pharmaceuticals & Biotechnology

Procter & Gamble Health Limited

ISIN: INE199A01012 · Data as of Oct 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

+1 funds

Total Value

₹846.81 Cr

Avg Weight

4.5%

New Entries

Exits

Top Holder

Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option 51%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #585

₹7.84 K Cr

Avg Mkt Cap · Jan-Jun 2023 (3yr ago)

→

₹8.92 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

+13.8%

3yr change

SEBI · AMFI Market Cap List

📋 What Changed This Month Procter & Gamble Health Limited is currently held by 20 active mutual funds with total exposure of ₹846.81 Cr. This month 2 funds entered and 1 fund exited. Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option has the highest allocation at 51%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Oct 2026 REFERENCE	20	₹847	48 / 49
Sep 2026	19	₹809	49 / 49	✅ Complete
Aug 2026	19	₹833	49 / 49	✅ Complete
Jul 2026	19	₹946	49 / 49	✅ Complete
Jun 2026	19	₹946	49 / 49	✅ Complete

📌 Portfolio changes below are based on Oct 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Oct 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (2)

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 1.26%

BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH 0.04%

▼ Exits (1)

WhiteOak Capital Pharma and Healthcare Fund 1.18%

↑ Increased (17)

Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option +50.52%

UTI - MNC Fund - Growth Option - Direct +0.22%

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth +0.37%

Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth +0.31%

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth +0.3%

Tata India Pharma & Healthcare Fund-Direct Plan-Growth +0.4%

Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth +0.3%

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth +0.28%

↓ Decreased (0)

No decreases this month

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight
Equity	17	2.23%
Small Cap	2	26.01%
Multi Cap	1	0.04%

All Holdings

Which 20 Active Funds Hold Procter & Gamble Health Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund	Small Cap	51%	₹393.91 Cr	+50.52%
UTI - MNC Fund - Growth Option - Direct UTI Mutual Fund	Equity	4.25%	₹107.67 Cr	+0.22%
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	3.56%	₹70.20 L	+0.37%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	3.19%	₹99.12 L	+0.31%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	3.15%	₹1.04 Cr	+0.3%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Tata Mutual Fund	Equity	3.15%	₹47.18 Cr	+0.4%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	3.14%	₹89.20 L	+0.3%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	2.99%	₹2.07 Cr	+0.28%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	2.95%	₹96.85 L	+0.29%
DSP Healthcare Fund - Direct Plan - Growth DSP Mutual Fund	Equity	2.42%	₹90.32 Cr	+0.06%
UTI Healthcare Fund - Direct Plan - Growth Option UTI Mutual Fund	Equity	1.98%	₹28.35 Cr	+0.03%
Aditya Birla Sun Life MNC Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	1.87%	₹53.71 Cr	+0.13%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND Aditya Birla Sun Life Mutual Fund	Equity	1.83%	₹19.96 Cr	+0.01%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth WhiteOak Capital Mutual Fund	Equity	1.26%	₹12.11 Cr	NEW
BAJAJ FINSERV SMALL CAP FUND - DIRECT - GROWTH Bajaj Finserv Mutual Fund	Small Cap	1.01%	₹27.56 Cr	+0.28%
Aditya Birla Sun Life Business Cycle Fund-Direct Growth Aditya Birla Sun Life Mutual Fund	Equity	0.94%	₹16.09 Cr	+0.02%
Tata India Consumer Fund-Direct Plan-Growth Tata Mutual Fund	Equity	0.62%	₹16.48 Cr	+0.33%
Aditya Birla Sun Life Consumption Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	0.45%	₹25.24 Cr	+0.02%
Baroda BNP Paribas Health and Wellness Fund Direct Growth Baroda BNP Paribas Mutual Fund	Equity	0.17%	₹85.28 L	—
BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH Bajaj Finserv Mutual Fund	Multi Cap	0.04%	₹71.68 L	NEW

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.